Kaul, UpendraBhatia, VineetGhose, TapanGupta, RipenKachru, RanjanSingh, Gyanti2008-11-122009-05-272008-11-122009-05-272008-11-12Kaul U, Bhatia V, Ghose T, Gupta R, Kachru R, Singh G. Angiographic follow-up of genous bioengineered stent in acute myocardial infarction (GENAMI)-a pilot study. Indian Heart Journal. 2008 Nov-Dec; 60(6): 532-5http://imsear.searo.who.int/handle/123456789/4797OBJECTIVE: GENAMI, an angiographic follow-up study was undertaken to evaluate the safety and efficacy of a new generation endothelial progenitor cell (EPC) capture stent, GENOUS during primary angioplasty for ST-elevation myocardial infarction (MI). METHODS: Eleven consecutive patients with acute ST-elevation MI underwent primary percutaneous coronary intervention (PCI) using a bio-engineered GENOUS EPC stent. RESULTS: Procedural success was 100%. Ten patients who survived underwent a follow-up angiography at 8 months. There was no instance of stent thrombosis during the follow-up period up to 12 months. The quantitative angiographic (quantitative coronary analysis [QCA]) follow-up data showed a late loss at 8 months of 0.97 +/- 0.94 mm and the late loss index was 44.35 +/- 40.47% with angiographic restenosis seen in 5 of 10 patients (50%). One of these patients with provocable ischemia underwent repeat PCI. CONCLUSIONS: The QCA data of this study shows a high late loss with frequent angiographic restenosis during follow-up with this stent during primary PCI for acute STEMI. This observation, with important clinical implications, needs to be confirmed in larger studies.engAdultAgedAngioplasty, Transluminal, Percutaneous CoronaryCoronary AngiographyCoronary Restenosis --prevention & controlCoronary Thrombosis --prevention & controlEndothelial CellsFemaleHumansMaleMiddle AgedMyocardial Infarction --prevention & controlPilot ProjectsProspective StudiesStem CellsStentsJournal Article